Your Article Summary
See Latest ArticlesA practical approach to using ciclosporin
Dermatology in Practice, 07/01/09
Ciclosporin is an immunosuppressant drug used in dermatology to treat patients with severe or recalcitrant psoriasis, or with severe atopic eczema. It has important adverse effects, particularly on the kidneys, so careful counselling and monitoring are required.
Related Articles
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia
British Journal of Haematology, 10/16/09
Relevance Score: 84%
Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus
Clinical Pharmacokinetics, 10/15/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09
Review: erythropoiesis-stimulating agents increase mortality in patients with cancer
Evidence-Based Medicine, 12/07/09
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/07/09
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Site of psoriasis (scalp or intergluteal/perianal), >=3 affected sites, and nail dystrophy predicted psoriatic arthritis in incident psoriasis
Evidence-Based Medicine, 12/07/09
Treatment of striae distensae with a TriPollar radiofrequency device: A pilot study
Journal of Dermatological Treatment , 12/07/09
Acute Generalized Exanthematous Pustulosis: A Rare Clinical Entity With Use of Piperacillin/Tazobactam
American Journal of Therapeutics, 12/07/09